Embolotherapy Market worth $5.0 billion by 2026 - Exclusive Report by MarketsandMarkets™

CHICAGO, May 13, 2021 /PRNewswire/ -- According to the new market research report "Embolotherapy Market by Product (Embolic Agents (Microspheres, Liquid Embolic Agents, Coil), Microcatheters), Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), Procedure (TACE, TARE), Enduser (Hospital, Clinics, ASC) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is valued at USD 3.4 billion in 2021 and is expected to reach USD 5.0 billion by 2026, at a CAGR of 8.0% during the forecast period.

Browse in-depth TOC on "Embolotherapy Market"

209 – Tables
35 – Figures
230 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830

The growth of the market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.

The microspheres subsegment of embolic agents products to hold major market share by 2026

Based on product, the market is further segmented into embolization coils (detachable coils and pushable coils), embolic agents (liquid embolic agents and microspheres), detachable balloons, embolic plug systems, and support devices (microcatheters and guidewires). The microspheres subsegment of embolic agent products commanded the largest share of the embolotherapy market in 2020 and the trend is expected to continue by 2026. Market growth is driven by the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies. Moreover, new product launches and approvals are further supporting the growth of the segment.

The liver cancer segment is projected to hold the largest share of the market by application during the forecast period of 2021 to 2026

Based on application, the embolotherapy market is segmented into oncology (liver cancer, kidney cancer, lung cancer, breast cancer, and other cancers), peripheral vascular diseases, urology, and nephrology (benign prostatic hyperplasia, uterine fibroids, and other urology & nephrology applications), neurology (brain aneurysm and cerebral arteriovenous malformations), and gastrointestinal disorders (GIT). The dominant share of this subsegment is attributed to the rising prevalence of liver cancer. 905,677 liver cancer cases were diagnosed globally in 2020 (Source: Globocan 2020). In the US alone, an estimated 34,000 new liver cancer cases are expected to be diagnosed each year (Source: CDC). Thus, the rising incidence of liver cancer is expected to fuel the growth of the segment in the next five years.

The transcatheter arterial radioembolization (TARE) segment is expected to register the highest growth rate during the forecast period

On the basis of procedure, the embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial chemoembolization (TACE), and transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT). The transcatheter arterial radioembolization (TARE) segment is expected to register the highest growth rate during the forecast period of 2021 to 2026. The growth of this segment is attributed to the advantages offered by TARE/SIRT, such as better clinical outcomes as compared to TACE, a lesser degree of the post-embolization syndrome, and increased cancer survival rates as compared to other techniques.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=185897830

Hospitals and clinics were the key end-users in the embolotherapy market

On the basis of end-users, the market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and other end users. In 2020, the hospital and clinics segment held the largest share of the market. The growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological procedures), increasing purchasing power of major healthcare providers across developed countries (owing to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries are the major factors that are expected to drive the demand for embolization devices in hospitals and clinics

North America is expected to dominate the global AST market in 2019

The embolotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa. North America is projected to hold the largest share of the regional market for embolotherapy products in 2020. The growing geriatric population, the increasing number of ASCs, and a growing preference for minimally invasive surgeries have resulted in the increasing adoption of embolotherapy procedures in the country.

The major players in the market include Boston Medical Corporation (US), Terumo Medical Systems (Japan), Medtronic (US), Johnson & Johnson (US), and Stryker Corporation (US). Other key players in the embolization therapy market include Sirtex Medical Limited (US), Abbott Laboratories (US), Acandis GmbH (Germany), Balt (France), Cook Medical (US), Kaneka Corporation (Japan), Penumbra, Inc. (US), Merit Medical Systems (US), Meril Life Sciences Pvt. Ltd. (India), Cardiva (US), Shape Memory Medical Inc. (US), Artio Medical Inc. (US), Rapid Medical (US), Emboline, Inc. (US), and IMbiotechnologies Ltd. (Canada), among others.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=185897830

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/interventional-oncology-market-203687164.html

Ambulatory Surgical Centers Market by Product (EHR, Practice Management, Telehealth, Healthcare Analytics, PHM, Supply Chain Management, RCM, Surgical planning, Quality Management), Specialty Type (Single, Multi-specialty) - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/ambulatory-surgical-center-market-182183086.html

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/embolotherapy-market.asp 
Visit Our Web Site: https://www.marketsandmarkets.com 
Content Source: https://www.marketsandmarkets.com/PressReleases/embolotherapy.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg